Finding Value And Defense In Big Pharma Stocks
By Margin of Safety on Fri, 2011-12-23 23:07
(via seekingalpha.com)
ong brand names, patent protection, regulatory approvals, and economies of scale are all key factors in the development and sustainability of a competitive advantage in the drug industry.
Shared:
Twitter: 0 LinkedIn: 0 Facebook: 0
Recent comments
3 weeks 3 hours ago
3 weeks 1 day ago
3 weeks 3 days ago
3 weeks 4 days ago
3 weeks 4 days ago
3 weeks 5 days ago
4 weeks 1 day ago
5 weeks 2 hours ago
5 weeks 4 hours ago
5 weeks 6 hours ago